Sit Swan 4

What Happened

• Sit Swan, a director of Edgewell Personal Care Company (EPC), received an award of 7,817 restricted stock equivalents on February 5, 2026. The award is recorded at $0.00 per unit (derivative/award), so no cash was exchanged in this transaction. These are not open-market purchases or sales but a form of equity compensation.

Key Details

• Transaction date: 2026-02-05; filing date: 2026-02-09 (timely filing).
• Transaction type: Award/Grant (code A); 7,817 restricted stock equivalents at $0.00.
• Amount paid/Value reported on Form 4: $0 (derivative award — no immediate cash consideration).
• Shares owned after transaction: not specified in this Form 4.
• Footnote: The restricted stock equivalents convert into Edgewell common stock on the day before the next annual meeting unless Sit Swan elects to defer conversion until termination of Board service.

Context

• Restricted stock equivalents (RSEs) are a common form of director compensation that convert into actual shares under specified conditions; they are not the same as an open-market buy (which some investors view as a bullish signal).
• This award should be interpreted as routine equity compensation for board service rather than a public market transaction or insider sale.